+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biotechnology - Industry Market Research Report

  • ID: 3972359
  • Report
  • February 2020
  • Region: Global
  • 46 pages
  • IBISWorld
1 of 3
Growing vitality: Industry operators will thrive as R&D funding rises alongside global demand for biotech products

FEATURED COMPANIES

  • F. Hoffmann-La Roche AG
  • Gilead Sciences Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • MORE

Global Biotechnology

Over the five years to 2019, the analyst expects revenue for the Global Biotechnology industry to increase with more profound growth tempered by falling investor confidence worldwide. Still, a jump in investor confidence and research and development funding in 2019 is expected to catalyze a spike in revenue that year. Over the five years to 2024, the industry is expected to continue to prosper, with the Asia-Pacific region, particularly China, South Korea, Taiwan and Singapore, investing significant amounts of capital to gain a strong foothold in the industry. Larger players emerging as profitable entities will continue pursuing low-risk strategies of success, such as buying out smaller operators to collect successful research for commercial-ready technologies, and partnering with academic institutions to support steady intellectual property expansion.

Operators in the Global Biotechnology industry primarily use living organisms or molecular and cellular techniques to develop products that are used in agriculture, food, industrial and medicine production.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • F. Hoffmann-La Roche AG
  • Gilead Sciences Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • MORE
ABOUT THIS INDUSTRY
  • Industry Definition
  • Main Activities
  • Similar Industries
  • Additional Resources
INDUSTRY AT A GLANCE

INDUSTRY PERFORMANCE
  • Executive Summary
  • Key External Drivers
  • Current Performance
  • Industry Outlook
  • Industry Life Cycle
PRODUCTS & MARKETS
  • Supply Chain
  • Products & Services
  • Demand Determinants
  • Major Markets
  • International Trade
  • Business Locations
COMPETITIVE LANDSCAPE
  • Market Share Concentration
  • Key Success Factors
  • Cost Structure Benchmarks
  • Basis of Competition
  • Barriers to Entry
  • Industry Globalization
MAJOR COMPANIES

OPERATING CONDITIONS
  • Capital Intensity
  • Technology & Systems
  • Revenue Volatility
  • Regulation & Policy
  • Industry Assistance
KEY STATISTICS
  • Industry Data
  • Annual Change
  • Key Ratios
JARGON & GLOSSARY
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • F. Hoffmann-La Roche AG
  • Gilead Sciences Inc.>Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co. Inc.
Note: Product cover images may vary from those shown
Adroll
adroll